RWM
FOLD

Raffa Wealth Management’s Amicus Therapeutics FOLD Stock Holding History

Raffa Wealth Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-96
Closed -$1.11K – 1143
2021
Q4 		$1.11K Hold
96
– – ﹤0.01% 831
2021
Q3 		$917 Hold
96
– – ﹤0.01% 851
2021
Q2 		$925 Sell
96
-1
-1% -$10 ﹤0.01% 862
2021
Q1 		$958 Sell
97
-20
-17% -$310 ﹤0.01% 840
2020
Q4 		$2.7K Buy
117
+20
+21% +$409 ﹤0.01% 481
2020
Q3 		$1.37K Sell
97
-13
-12% -$189 ﹤0.01% 581
2020
Q2 		$1.66K Hold
110
– – ﹤0.01% 519
2020
Q1 		$1.02K Hold
110
– – ﹤0.01% 588
2019
Q4 		$1.07K Hold
110
– – ﹤0.01% 606
2019
Q3 		$882 Buy
+110
New +$1.19K ﹤0.01% 641

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raffa Wealth Management's FOLD Position: Q1 2022 in Review

Raffa Wealth Management sold out of Amicus Therapeutics (FOLD) in Q1 2022, closing a stake of 96 shares — an estimated $1.11K sold.

Raffa Wealth Management first reported a position in FOLD in Q3 2019 and held it in 10 quarters. The position peaked at $2.7K in Q4 2020. 217 funds tracked by Wall St. Rank hold FOLD as of Q1 2022.

  • Raffa Wealth Management reported no remaining Amicus Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Raffa Wealth Management sold 96 Amicus Therapeutics shares in Q1 2022, an estimated $1.11K.
  • Raffa Wealth Management first reported a position in Amicus Therapeutics in Q3 2019 and held it in 10 quarters.
  • Raffa Wealth Management's Amicus Therapeutics position peaked at $2.7K in Q4 2020.
  • 217 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2022.

Based on Raffa Wealth Management's 13F filing for Q1 2022, filed 27 Jul 2026.